Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-25 @ 5:04 AM
NCT ID:
NCT02423018
Eligibility Criteria:
Inclusion Criteria:
* Admitted to the Medical Withdrawal Unit at the Centre for Addiction and Mental Health for medically assisted withdrawal from benzodiazepines, zopiclone and/or zolpidem
* Willing and capable to give written informed consent
Exclusion Criteria:
* Patients who are hypersensitive to pregabalin or to any ingredient in the formulation or component of the container.
* Pregnant or nursing women
* Renal impairment (creatinine clearance less than 60ml/min)
* History of angioedema, or taking drugs associated with angioedema (e.g., ACE-inhibitors).
* Currently taking pregabalin or gabapentin
* Currently taking thiazolidinedione antidiabetic agents (e.g., rosiglitazone, pioglitazone)
* Previous history of pregabalin or gabapentin abuse
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02423018
Study Brief:
Protocol Section:
NCT02423018